(ECAT) BlackRock ESG Capital - Ratings and Ratios
ESG, Investment, Funds, Portfolios, Asset Management
Description: ECAT BlackRock ESG Capital
The BlackRock ESG Capital Allocation Trust is a closed-end investment company listed on the NYSE under the ticker symbol ECAT. As a specialist in asset management, the trust focuses on ESG (Environmental, Social, and Governance) considerations in its investment decisions, aligning with the growing demand for sustainable investing.
From a technical analysis perspective, ECATs recent price action indicates a relatively stable trend, with its last price being $15.66. The stock is currently trading above its 50-day and 200-day simple moving averages (SMA50 and SMA200), suggesting a positive short-term and long-term outlook. The Average True Range (ATR) of 0.21, translating to 1.36%, indicates moderate volatility. Considering these technical indicators, a potential trading range could be between $15.50 and $16.00, with a possible breakout above $16.01, its 52-week high.
Fundamentally, ECAT has a market capitalization of approximately $1.6 billion, categorizing it as a mid-cap stock. The price-to-earnings (P/E) ratio of 6.79 is relatively low, suggesting that the stock might be undervalued compared to its peers in the asset management industry. The return on equity (RoE) of 13.12% is a positive indicator of the companys profitability and its ability to generate returns for shareholders.
Combining both technical and fundamental analysis, a forecast for ECAT could be cautiously optimistic. If the stock can break through its 52-week high of $16.01, it may attract more investors, potentially driving the price higher. Conversely, if it falls below its SMA50 at $15.14, it could signal a downturn. Given its low P/E ratio and respectable RoE, theres a fundamental basis for the stock to appreciate over time, assuming the ESG-focused investment strategy continues to attract capital. A potential price target could be in the range of $17.00 to $18.00 over the next 12 to 18 months, contingent upon continued stability in the financial markets and the asset management sector.
Additional Sources for ECAT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ECAT Stock Overview
Market Cap in USD | 1,626m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2021-09-28 |
ECAT Stock Ratings
Growth Rating | 44.9 |
Fundamental | - |
Dividend Rating | 94.3 |
Rel. Strength | -9.74 |
Analysts | - |
Fair Price Momentum | 22.24 USD |
Fair Price DCF | 45.31 USD |
ECAT Dividends
Dividend Yield 12m | 23.20% |
Yield on Cost 5y | 28.85% |
Annual Growth 5y | 131.28% |
Payout Consistency | 80.0% |
Payout Ratio | 120.7% |
ECAT Growth Ratios
Growth Correlation 3m | 96.1% |
Growth Correlation 12m | 63.8% |
Growth Correlation 5y | 79% |
CAGR 5y | 7.18% |
CAGR/Max DD 5y | 0.22 |
Sharpe Ratio 12m | 1.77 |
Alpha | 2.30 |
Beta | 0.716 |
Volatility | 11.54% |
Current Volume | 413.5k |
Average Volume 20d | 280.2k |
Stop Loss | 15.8 (-3.5%) |
As of July 12, 2025, the stock is trading at USD 16.38 with a total of 413,468 shares traded.
Over the past week, the price has changed by +0.86%, over one month by +2.30%, over three months by +15.48% and over the past year by +13.13%.
Partly, yes. Based on ValueRay´s Analyses, BlackRock ESG Capital (NYSE:ECAT) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 44.90 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ECAT is around 22.24 USD . This means that ECAT is currently undervalued and has a potential upside of +35.78% (Margin of Safety).
BlackRock ESG Capital has no consensus analysts rating.
According to our own proprietary Forecast Model, ECAT BlackRock ESG Capital will be worth about 25.5 in July 2026. The stock is currently trading at 16.38. This means that the stock has a potential upside of +55.62%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.5 | 55.6% |